Notice of Intent to Sole Source – Quest Diagnostics

Closed Special Notice Posted

Solicitation number
25-008287
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
07094

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health Clinical Center has issued a Special Notice announcing its intent to award a sole source contract to Quest Diagnostics Inc. for laboratory support services. This notice pertains to the Observational Study of Dietary Intake and Dietary Behaviors in Adults with Sickle Cell Disease (IRB #000518), a clinical study being conducted by the NIH. The contract will enable eligible patients who cannot travel to the NIH Clinical Center in Bethesda, Maryland to complete required lab work at Quest Diagnostics facilities in accordance with the study protocol. The acquisition falls under NAICS code 339112 for Surgical and Medical Instrument Manufacturing and PSC code 6515 for Medical Instruments, Equipment, and Supplies. Quest Diagnostics Inc., located in Secaucus, New Jersey, has been identified as the sole source vendor for this fixed-price purchase order.

The purpose of this sole source acquisition is to leverage Quest Diagnostics' existing infrastructure and established relationship with the NIH to ensure timely and cost-efficient completion of laboratory data collection requirements for the sickle cell disease study. The NIH is utilizing FAR Part 13 Simplified Acquisition Procedures, which allows contracting officers to solicit from one source when circumstances deem only one source reasonably available for purchases not exceeding the simplified acquisition threshold. Interested parties may submit comments expressing their interest and capabilities to Contract Specialist Kristin Nagashima at Kristin.nagashima@nih.gov by August 29, 2025 at 11:00 AM EST. However, the notice explicitly states that this is an intent notice rather than a request for quotation, and no solicitation document will be issued. The government reserves sole discretion in determining whether to compete the requirement based on any responses received. The contract will be awarded on a firm fixed-price basis to support the NIH Clinical Center's research objectives.

Notice text

The purpose of this acquisition is to collaborate with a vendor as part of clinical study,

the Observational Study of Dietary Intake and Dietary Behaviors in Adults with Sickle

Cell Disease (IRB #000518). This collaboration will provide eligible patients who are

unable to travel to the National Institutes of Health (NIH) Clinical Center (CC) the option to complete required lab work in alignment with the study protocol. This contract with Quest Diagnostic will be used to meet study objectives.

•            Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

•            NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•            Place of Performance: Bethesda, MD 20892 USA

POTS: 25-008287

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Quest Diagnostics Inc., located at 500 Plaza Dr, Secaucus, NJ 07094, on a firm fixed price sole source award basis to provide lab support to the National Institutes of Health CC.

The proposed vendor, Quest Diagnostics, has the infrastructure for the collection of laboratory data for this study, as well as a unique familiarity with the needs of our lab. The established relationship with Quest Diagnostics ensures that study requirements are completed in a timely and cost-efficient matter.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by August 29, 2025 at 11am EST.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source – Boston Scientific Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Q301--leptomeningeal and coronary research services. NAICS 541715 Veterans Integrated Service Network 22 No set-aside
Service agreement for the cytena f sight cell sorter base + two option year Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity